Loading...
Loading...
Onward Medical N.V./ADR
Onward Medical N.V./ADR. Spoken Alpha tracks ONWRY's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks ONWRY's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ONWRY.
curl https://api.spokenalpha.com/v1/companies/ONWRY| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.25 | $0.91 | +37.2% | -1.1% | +1.8% |
| Q4 FY2026 | $1.46 | $1.03 | +41.5% | -2.8% | -1.4% |
| Q3 FY2026 | $1.55 | $1.09 | +42.1% | +6.7% | +7.0% |
| Q2 FY2026 | $1.46 | $1.07 | +36.6% | +1.7% | +0.4% |
| Q1 FY2025 | $1.54 | $1.10 | +40.4% | +0.8% | +3.1% |
| Q4 FY2025 | $1.50 | $1.07 | +40.5% | -4.0% | -6.7% |
| Q3 FY2025 | $1.65 | $1.19 | +38.4% | +3.5% | +0.9% |
| Q2 FY2025 | $1.48 | $1.14 | +29.6% | +5.7% | +5.7% |
| Q1 FY2024 | $1.33 | $1.00 | +33.3% | -3.7% | -6.6% |
| Q4 FY2024 | $1.54 | $1.13 | +36.6% | -1.9% | -3.2% |